These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 35950038)

  • 1. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
    Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    World J Urol; 2024 Mar; 42(1):152. PubMed ID: 38483586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group).
    Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Ann Surg Oncol; 2024 Mar; 31(3):2154-2162. PubMed ID: 38200385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Biomarkers for Biochemical Recurrence after Radical Prostatectomy for Prostate Cancer Using Clinical and MRI-Derived Semantic Features.
    Guerra A; Alves FC; Maes K; Maio R; Villeirs G; Mouriño H
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Negative Impact of Inflammation-Related Parameters in Prostate Cancer after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (the MSUG94 Group).
    Murase K; Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137801
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy.
    Shimodaira K; Inoue R; Hashimoto T; Satake N; Shishido T; Namiki K; Harada K; Nagao T; Ohno Y
    Cancer Med; 2024 Mar; 13(5):e7086. PubMed ID: 38477506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis.
    Wang L; Wang B; Ai Q; Zhang Y; Lv X; Li H; Ma X; Zhang X
    Int Urol Nephrol; 2017 Jun; 49(6):995-1005. PubMed ID: 28238148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic differences among Grade Group 4 subgroups in robotic-assisted radical prostatectomy.
    Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kato D; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    BJUI Compass; 2022 Sep; 3(5):392-399. PubMed ID: 35950038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
    Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
    Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Biochemical Recurrence and Correlation with Various Parameters After Robotic-Assisted Radical Prostatectomy: a Single Center Experience.
    Singh M; Kathuria S; Jain S; Rasool S; Tyagi V; Gupta M; Pahwa M; Pandey H; Sharma A
    Indian J Surg Oncol; 2022 Sep; 13(3):661-667. PubMed ID: 36187532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term oncological and surgical outcomes of robot-assisted radical prostatectomy: A retrospective multicenter cohort study in Japan (the MSUG94 group).
    Kato D; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Asian J Endosc Surg; 2022 Oct; 15(4):745-752. PubMed ID: 35508895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
    Abdollah F; Dalela D; Sood A; Sammon J; Jeong W; Beyer B; Fossati N; Rogers CG; Diaz-Insua M; Peabody J; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    World J Urol; 2016 Oct; 34(10):1357-66. PubMed ID: 26873596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Gleason Grade 3 as a Predictive Factor for Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
    Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 35893105
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort.
    Würnschimmel C; Pose RM; Wenzel M; Tian Z; Incesu RB; Karakiewicz P; Graefen M; Tilki D
    Eur Urol; 2021 Oct; 80(4):400-404. PubMed ID: 34162491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer.
    Mori K; Sharma V; Comperat EM; Sato S; Laukhtina E; Schuettfort VM; Pradere B; Sari Motlagh R; Mostafaei H; Quhal F; Kardoust Parizi M; Abufaraj M; Karakiewicz PI; Egawa S; Tilki D; Boorjian SA; Shariat SF
    Ann Surg Oncol; 2021 Dec; 28(13):9179-9187. PubMed ID: 34117577
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.